Beijnen JH - Search Results

1

Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs.

Breedveld P, Beijnen JH, Schellens JH. Breedveld P, et al. Among authors: beijnen jh. Trends Pharmacol Sci. 2006 Jan;27(1):17-24. doi: 10.1016/j.tips.2005.11.009. Epub 2005 Dec 5. Trends Pharmacol Sci. 2006. PMID: 16337012 Review.

2

New cytotoxic drugs and targets in oncology.

Beijnen JH. Beijnen JH. Pharm Weekbl Sci. 1992 Aug 21;14(4A):258-67. doi: 10.1007/BF01962548. Pharm Weekbl Sci. 1992. PMID: 1437508 Review.

3

Didanosine, a new antiretroviral drug. A review.

Franssen RM, Meenhorst PL, Koks CH, Beijnen JH. Franssen RM, et al. Among authors: beijnen jh. Pharm Weekbl Sci. 1992 Oct 16;14(5):297-304. doi: 10.1007/BF01977617. Pharm Weekbl Sci. 1992. PMID: 1437513 Review.

4

Pharmacology, bio-analysis and pharmacokinetics of the vinca alkaloids and semi-synthetic derivatives (review).

van Tellingen O, Sips JH, Beijnen JH, Bult A, Nooijen WJ. van Tellingen O, et al. Among authors: beijnen jh. Anticancer Res. 1992 Sep-Oct;12(5):1699-715. Anticancer Res. 1992. PMID: 1444238 Review.

5

Phase I study of vintriptol, a tryptophan ester of vinblastine.

Oosterkamp HM, Vlasveld LT, Wanders J, Beijnen JH, van Tellingen O, Dubbelman AC, Simonetti GP, Franklin HR, Vermorken JB, Ten Bokkel Huinink WW. Oosterkamp HM, et al. Among authors: beijnen jh. Eur J Cancer. 1991;27(10):1222-6. doi: 10.1016/0277-5379(91)90085-r. Eur J Cancer. 1991. PMID: 1835590 Clinical Trial.

6

Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusion.

van Warmerdam LJ, ten Bokkel Huinink WW, Rodenhuis S, Koier I, Davies BE, Rosing H, Maes RA, Beijnen JH. van Warmerdam LJ, et al. Among authors: beijnen jh. J Clin Oncol. 1995 Jul;13(7):1768-76. doi: 10.1200/JCO.1995.13.7.1768. J Clin Oncol. 1995. PMID: 7602366 Clinical Trial.

7

Taxanes: a new class of antitumor agents.

Huizing MT, Misser VH, Pieters RC, ten Bokkel Huinink WW, Veenhof CH, Vermorken JB, Pinedo HM, Beijnen JH. Huizing MT, et al. Among authors: beijnen jh. Cancer Invest. 1995;13(4):381-404. doi: 10.3109/07357909509031919. Cancer Invest. 1995. PMID: 7627725 Review.

8

Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein.

Zaman GJ, Lankelma J, van Tellingen O, Beijnen J, Dekker H, Paulusma C, Oude Elferink RP, Baas F, Borst P. Zaman GJ, et al. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7690-4. doi: 10.1073/pnas.92.17.7690. Proc Natl Acad Sci U S A. 1995. PMID: 7644478 Free PMC article.

9

Paclitaxel (Taxol) concentrations in brain tumor tissue.

Heimans JJ, Vermorken JB, Wolbers JG, Eeltink CM, Meijer OW, Taphoorn MJ, Beijnen JH. Heimans JJ, et al. Among authors: beijnen jh. Ann Oncol. 1994 Dec;5(10):951-3. doi: 10.1093/oxfordjournals.annonc.a058736. Ann Oncol. 1994. PMID: 7696168

10

High-dose chemotherapy regimens for solid tumors.

van der Wall E, Beijnen JH, Rodenhuis S. van der Wall E, et al. Among authors: beijnen jh. Cancer Treat Rev. 1995 Mar;21(2):105-32. doi: 10.1016/0305-7372(95)90023-3. Cancer Treat Rev. 1995. PMID: 7758003 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results